Inflammatory markers in antipsychotic-naive patients with nonaffective psychosis and deficit vs. nondeficit features

被引:64
|
作者
Garcia-Rizo, Clemente [1 ]
Fernandez-Egea, Emilio [2 ,3 ]
Oliveira, Cristina [1 ]
Justicia, Azucena [2 ]
Bernardo, Miguel [1 ,4 ,7 ]
Kirkpatrick, Brian [5 ,6 ]
机构
[1] Univ Barcelona, Hosp Clin, Inst Neurosci, Schizophrenia Program,Dept Psychiat, E-08036 Barcelona, Spain
[2] Univ Cambridge, Addenbrookes Hosp, Dept Psychiat, Cambridge CB2 0QQ, England
[3] Cambridgeshire & Peterborough NHS Fdn Trust, Huntingdon PE29 3RJ, England
[4] Inst Biomed Res Agusti Pi i Sunyer IDIBAPS, Barcelona, Spain
[5] Texas A&M Univ, Coll Med, Dept Psychiat, Temple, TX 76508 USA
[6] Scott & White Healthcare, Temple, TX USA
[7] CIBERSAM, Madrid, Spain
关键词
Deficit schizophrenia; Interleukin; 6; C-reactive protein; Glucose tolerance; Negative symptoms; First episode psychosis; C-REACTIVE PROTEIN; PLACEBO-CONTROLLED TRIAL; IV FIELD TRIAL; SUMMER BIRTH; CELECOXIB AUGMENTATION; SERUM INTERLEUKIN-6; ADJUNCTIVE THERAPY; COX-2; INHIBITORS; DOUBLE-BLIND; SCHIZOPHRENIA;
D O I
10.1016/j.psychres.2011.08.014
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Newly diagnosed, antipsychotic-naive patients with nonaffective psychosis appear to have increases in pro-inflammatory cytokines. Patients characterized by primary, enduring negative symptoms (deficit symptoms) differ from patients without such features with regard to course of illness, treatment response, risk factors and metabolic disturbances. We hypothesized that they would also differ on concentrations of the inflammatory markers interleukin-6 (IL6) and C-reactive protein (CRP). Newly diagnosed, antipsychotic-naive patients with nonaffective psychosis were categorized into deficit (N = 20) and nondeficit (N = 42) groups, and were matched on age, gender, body mass index, smoking, cortisol level, socioeconomic status, and the severity of psychotic symptoms. Fasting concentrations of IL6 were significantly higher in deficit (mean [S.D.]) (8.0 pg/ml [12.7]) than nondeficit patients (0.3 pg/ml [1.3]). CRP levels were also significantly higher in the deficit patients (0.3 mg/dl [0.4]) vs. (0.2 mg/dl [0.4]), respectively. In contrast, 2-h glucose concentrations (2HG) in a glucose tolerance test were lower in the deficit than the nondeficit group. Our results show a double dissociation with regard to glucose intolerance and inflammation: the deficit group has greater inflammation, but less severe glucose intolerance. These results provide further evidence for the validity of the deficit/nondeficit categorization. (C) 2011 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:212 / 215
页数:4
相关论文
共 39 条
  • [21] Neural markers of negative symptom outcomes in distributed working memory brain activity of antipsychotic-naive schizophrenia patients
    Nejad, Ayna B.
    Madsen, Kristoffer H.
    Ebdrup, Bjorn H.
    Siebner, Hartwig R.
    Rasmussen, Hans
    Aggernaes, Bodil
    Glenthoj, Birte Y.
    Baare, William F. C.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2013, 16 (06) : 1195 - 1204
  • [22] Treatment response after 6 and 26 weeks is related to baseline glutamate and GABA levels in antipsychotic-naive patients with psychosis
    Bojesen, Kirsten B.
    Ebdrup, Bjorn H.
    Jessen, Kasper
    Sigvard, Anne
    Tangmose, Karen
    Edden, Richard A. E.
    Larsson, Henrik B. W.
    Rostrup, Egill
    Broberg, Brian V.
    Glenthoj, Birte Y.
    PSYCHOLOGICAL MEDICINE, 2020, 50 (13) : 2182 - 2193
  • [23] Is Increased Glutamate in the Associative Striatum a Reliable Biomarker in Antipsychotic-Naive First-Episode Psychosis Patients?
    de la Fuente-Sandoval, Camilo
    Plitman, Eric
    Reyes-Madrigal, Francisco
    Chavez, Sofia
    Gomez-Cruz, Gladys
    Leon-Ortiz, Pablo
    Graff-Guerrero, Ariel
    NEUROPSYCHOPHARMACOLOGY, 2015, 40 : S556 - S557
  • [24] Letter to the Editor: Lipid profile disturbances in antipsychotic-naive patients with first-episode non-affective psychosis
    Perry, B. I.
    Singh, S. P.
    SCHIZOPHRENIA RESEARCH, 2018, 192 : 461 - 462
  • [25] Cerebral blood flow in striatum is increased by partial dopamine agonism in initially antipsychotic-naive patients with psychosis
    Bojesen, Kirsten Borup
    Glenthoj, Birte Yding
    Sigvard, Anne Korning
    Tangmose, Karen
    Raghava, Jayachandra Mitta
    Ebdrup, Bjorn Hylsebeck
    Rostrup, Egill
    PSYCHOLOGICAL MEDICINE, 2023, 53 (14) : 6691 - 6701
  • [26] Abnormal white matter integrity in antipsychotic-naive first-episode psychosis patients assessed by a DTI principal component analysis
    Alvarado-Alanis, Patricia
    Leon-Ortiz, Pablo
    Reyes-Madrigal, Francisco
    Favila, Rafael
    Rodriguez-Mayoral, Oscar
    Nicolini, Humberto
    Azcarraga, Mariana
    Graff-Guerrero, Ariel
    Rowland, Laura M.
    de la Fuente-Sandoval, Camilo
    SCHIZOPHRENIA RESEARCH, 2015, 162 (1-3) : 14 - 21
  • [27] Lower Vitamin C Levels Are Associated With Less Improvement in Negative Symptoms in Initially Antipsychotic-Naive Patients With First-Episode Psychosis
    Myken, Anders N.
    Ebdrup, Bjorn H.
    Sorensen, Mikkel E.
    Broberg, Brian, V
    Skjerbaek, Martin W.
    Glenthoj, Birte Y.
    Lykkesfeldt, Jens
    Nielsen, Mette O.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2022, 25 (08) : 613 - 618
  • [28] The predictive value of early treatment response in antipsychotic-naive patients with first-episode psychosis: Haloperidol versus olanzapine
    Rasmussen, Sean A.
    Rosebush, Patricia I.
    Anglin, Rebecca E.
    Mazurek, Michael F.
    PSYCHIATRY RESEARCH, 2016, 241 : 72 - 77
  • [29] Contrasting Frontoparietal Network Connectivity in Antipsychotic Medication-Naive First-Episode Psychosis Patients Who Do and Do Not Display Features of the Deficit Syndrome
    King, Victoria L.
    Lahti, Adrienne C.
    Maximo, Jose O.
    Ver Hoef, Lawrence W.
    John, Sooraj
    Kraguljac, Nina, V
    SCHIZOPHRENIA BULLETIN, 2022, 48 (06) : 1344 - 1353
  • [30] Spontaneous Parkinsonism Is Associated With Cognitive Impairment in Antipsychotic-Naive Patients With First-Episode Psychosis: A 6-Month Follow-up Study
    Cuesta, Manuel J.
    Sanchez-Torres, Ana M.
    Garcia de Jalon, Elena
    Campos, Maria S.
    Ibanez, Berta
    Moreno-Izco, Luca
    Peralta, Victor
    SCHIZOPHRENIA BULLETIN, 2014, 40 (05) : 1164 - 1173